Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.72 |
| ▸ | PLA2G4B | P0C869 | 7/20 | 0.70 |
| ▸ | RARB | P10826 | 4/20 | 0.66 |
| ▸ | HTT | P42858 | 3/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | APEX1 | P27695 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5375208 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL430092 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL26091696 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL9106297 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL4652780 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL4653588 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL5478282 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL9221792 | 1.00 | TP53 (0.72) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL3662484 | 0.98 | TP53 (0.69) | TP53TSHRPLA2G4BRARBHTT | |
| SCHEMBL10408397 | 0.95 | RARB (0.74) | TP53TSHRPLA2G4BRARBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260063833-A1 | OPTICAL ELEMENT | HAYASHI TELEMPU CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| CN-119662151-A | Reworkable thermal viscosity-reducing foam adhesive tape and preparation method thereof | 苏州世华新材料科技股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119105192-A | Polarization conversion element, image projection apparatus provided with same, and method for manufacturing phase difference element | 林特琅普股份有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-113122269-B | Ultraviolet light absorber | 光学转变公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117343025-A | Polymerizable liquid crystal compound, polymerizable composition, retardation film, transfer laminate, and optical member | 大日本印刷株式会社 | 2024-01-05 | — | — | CN | disclosed |
| CN-111201220-B | Polymerizable liquid crystal compound, polymerizable composition, retardation film, transfer laminate, and optical member | 大日本印刷株式会社 | 2023-10-17 | — | — | CN | disclosed |
| CN-113474691-B | Optical layered body and method for producing same | 林特琅普股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| US-20230137250-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, RETARDATION FILM, METHOD FOR PRODUCING RETARDATION FILM, TRANSFER LAMINATE, OPTICAL MEMBER, METHOD FOR PRODUCING OPTICAL MEMBER, AND DISPLAY DEVICE | DAI NIPPON PRINTING CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| CN-112470046-B | Retardation film and method for producing same | 林特琅普股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-108368425-B | Liquid crystal mixture and liquid crystal display | 默克专利股份有限公司（DE） | 2023-01-13 | — | — | CN | disclosed |
| EP-0445629-A2 | Process of preparing liquid crystal compositions containing multiple oriented mesogens | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | disclosed |
| EP-0445628-A2 | Polymerizable nematic monomer compositions | HERCULES INCORPORATED (US) | 1991-09-11 | — | — | EP | disclosed |
| EP-0376310-A2 | Mesomorphic polymer, monomeric mesomorphic compound, liquid crystal composition and liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 1990-07-04 | — | — | EP | disclosed |
| US-4925589-A | ADDITION ACRYLIC TYPE POLYMER | HOFFMANN-LA ROCHE INC. (US) | 1990-05-15 | — | — | US | disclosed |
| EP-0357850-A1 | Polymer composition, capable of forming a chiral nematic mesophase | STAMICARBON B.V. (NL) | 1990-03-14 | — | — | EP | disclosed |
| WO-1989011496-A1 | SIDE-CHAIN POLYMERS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1989-11-30 | — | — | WO | disclosed |
| EP-0322708-A2 | Polymers with amide groups in the side chains | F. HOFFMANN-LA ROCHE AG (CH) | 1989-07-05 | — | — | EP | disclosed |
| US-4631328-A | LIQUID CRYSTALS | BASF AKTIENGESELLSCHAFT (DE) | 1986-12-23 | — | — | US | disclosed |
| EP-0090282-B1 | POLYMERS HAVING MESOGEN GROUPS AND COLOURING MATTER IN THE SIDE CHAIN | BASF Aktiengesellschaft (DE) | 1986-02-05 | — | — | EP | disclosed |
| EP-0090282-A1 | Polymers having mesogen groups and colouring matter in the side chain | BASF Aktiengesellschaft (DE) | 1983-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230137250-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, RETARDATION FILM, METHOD FOR PRODUCING RETARDATION FILM, TRANSFER LAMINATE, OPTICAL MEMBER, METHOD FOR PRODUCING OPTICAL MEMBER, AND DISPLAY DEVICE | TRRAP, CDH1, LRRFIP1 | TP53 3841/4885TSHR 4394/4885PLA2G4B 2901/4885 |
| US-20260063833-A1 | OPTICAL ELEMENT | OCIAD2, OCIAD1, IGF1R | TP53 2155/4885TSHR 318/4885PLA2G4B 2092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.